Stryker Corp (N:SYK)

Apr 01, 2024 04:05 pm ET
Stryker to announce financial results for its first quarter of fiscal year 2024
Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2024 on Tuesday, April 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The...
Mar 26, 2024 04:05 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2024 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 9, 2024 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include...
Mar 26, 2024 03:10 am ET
Stryker launches Gamma4 Hip Fracture Nailing System in Europe
Stryker (NYSE:SYK), a global leader in medical technologies, today announced the release of its Gamma4 Hip Fracture Nailing System in most of the European markets. The newest Gamma system will provide surgeons with the next generation of Stryker’s intramedullary nailing system. The Gamma4 system is designed to treat hip and femur fractures and streamline procedural workflows for surgeons. The system received the CE certification in Europe in September 2023.
Mar 21, 2024 07:15 am ET
Stryker completes acquisition of SERF SAS
MAHWAH, N.J., USA, March 21, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France-based joint replacement company, from Menix.
Feb 28, 2024 02:10 am ET
First shoulder arthroplasty surgeries using Stryker’s Blueprint® Mixed Reality Guidance System completed in Europe
Stryker (NYSE:SYK), a global leader in medical technologies, today announced that the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance in Europe have been successfully completed by Professor Julien Berhouet, MD, PhD, CHRU Tours Hospital, France, and Dr. Lionel Neyton, MD, orthopaedic shoulder surgeon at Centre Orthopédique Santy and Hôpital Privé Jean Mermoz in Lyon, France.
Feb 13, 2024 07:00 am ET
Stryker showcases commitment to innovation at AAOS 2024 Annual Meeting
MAHWAH, N.J., Feb. 13, 2024 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technology, showcases its commitment to innovation and technological advancement in Joint Replacement with the introduction of Triathlon® Hinge as well as the continued evolution of Mako SmartRobotics™ at this year's American Academy of Orthopaedic Surgeons' (AAOS) 2024 Annual Meeting in San Francisco.
Feb 09, 2024 03:15 am ET
CapitalGainsReport Sector Spotlight: Orthobiologics Watchlist (ORHB, ZBH, GMED, SYK)
Orthobiologics represents a dynamic field within healthcare where the body's natural healing mechanisms address osteoarthritis and enhance recovery from tendon and ligament injuries. These therapies signify a significant evolution in medical treatment, offering promising solutions for patients worldwide.
Feb 07, 2024 08:00 am ET
Stryker declares a $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable April 30, 2024 to shareholders of record at the close of business on March 29, 2024, representing an increase of 6.7% versus the...
Feb 05, 2024 08:00 am ET
Stryker to participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day
Stryker (NYSE:SYK) will participate in Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at Citigroup Headquarters, New York, New York. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason...
Jan 31, 2024 08:31 am ET
Thinking about trading options or stock in Stryker, Meta Platforms, PayPal, Novo Nordisk, or Schlumberger?
NEW YORK, Jan. 31, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SYK, META, PYPL, NVO, and SLB.
Jan 31, 2024 08:10 am ET
Stryker Expands Prophecy® Surgical Planning System to Include the New Footprint™, Offering Surgeons a Comprehensive View of the Foot and Ankle
Stryker (NYSE: SYK), a global leader in medical technologies, today announced the launch of Prophecy Footprint, an expansion of the Prophecy Surgical Planning system, offering comprehensive surgical planning across the entire foot. The system will be demonstrated at the
Jan 30, 2024 04:05 pm ET
Stryker reports 2023 operating results and 2024 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2023: Fourth Quarter Results Reported net sales increased 11.8% to $5.8 billionOrganic net sales increased 11.4%Reported operating income margin...
Jan 22, 2024 03:00 am ET
Top 4 Spinal Injury Stocks for 2024 (NRX.V, NVRO, SYK, BSX)
Investors eyeing dynamic opportunities in healthcare should take note of the burgeoning growth anticipated in the spinal cord injury market. Projections for robust advancements, driven by enhanced diagnosis and increased global healthcare spending, signal a lucrative trajectory from 2023 to 2032, with a significantly positive CAGR, according to Delveinsights.
Jan 17, 2024 08:00 am ET
New Intermediate Nail and RC Lag Screw Expand Gamma4 Portfolio to Meet the Needs of Surgeons and Their Patients
Stryker (NYSE: SYK), one of the world’s leading medical technologies companies, has expanded its Gamma4 Hip Fracture Nailing System, with the addition of an intermediate nail, the RC Lag Screw, and an anti-rotation clip with sleeve components. Since its launch in August of 2022, the Gamma4 System has been used in over 19,000 cases across more than 850 facilities, solidifying its position as a leading choice in orthopaedic procedures.
Jan 10, 2024 08:35 am ET
First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that the first shoulder arthroplasty surgeries using Blueprint® Mixed Reality (MR) Guidance have been successfully completed by Dr. Joaquin Sanchez-Sotelo, MD, PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health Care London, Canada.
Jan 08, 2024 08:00 am ET
Stryker announces 2023 sales surpassed $20 billion
Stryker (NYSE:SYK) announced today that it surpassed $20 billion in annual sales for the first time in its history during the month of December, 2023. “We are excited to surpass this major milestone and to share with our employees as we have our...
Jan 05, 2024 08:00 am ET
Stryker to announce financial results for its fourth quarter and full year 2023
Stryker (NYSE:SYK) announced that it will report financial results for fourth quarter and full year 2023 on Tuesday, January 30, 2024.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
Dec 19, 2023 03:00 am ET
4 Orthobiologic Stocks Set To Soar In 2024
Welcome to the transformative landscape of orthobiologics, where cutting-edge treatments utilize the body's own cells and healing factors to reverse orthoarthritis effects and expedite recovery from tendon and ligament injuries. These innovations, naturally derived and featuring stem cells, represent a paradigm shift in healthcare.
Dec 18, 2023 08:00 am ET
Stryker announces intent to acquire SERF SAS, enhancing its global joint replacement leadership
MAHWAH, N.J., USA, Dec. 18, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, announced today that it has executed a binding offer to Menix to acquire SERF SAS, a France-based joint replacement company.
Dec 07, 2023 08:00 am ET
Stryker announces intention to nominate a new director, Rachel Ruggeri
Stryker (NYSE:SYK) announced today that its Board of Directors intends to nominate Rachel Ruggeri for election to the Company’s Board of Directors at Stryker’s 2024 Annual Meeting of Shareholders, which is expected to be held on May 9, 2024. Ms....
Dec 06, 2023 08:00 am ET
Stryker announces Dr. Srikant Datar will retire from Board of Directors
Stryker (NYSE:SYK) announced today that after 15 years of distinguished service, Dr. Srikant Datar has notified the Company that he will not stand for re-election at Stryker's 2024 Annual Meeting of Shareholders, which is expected to be held on May...
Dec 05, 2023 08:00 am ET
Stryker declares a $0.80 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.80 per share payable January 31, 2024 to shareholders of record at the close of business on December 29, 2023, representing an increase of 6.7% versus...
Nov 02, 2023 04:17 pm ET
Stryker reports third quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2023: Third Quarter Results Reported net sales increased 9.6% to $4.9 billionOrganic net sales increased 9.2%Reported operating income margin of 19.0%Adjusted...
Oct 30, 2023 04:05 pm ET
Stryker to participate in the 6th Annual Evercore ISI HealthCONx Conference
Stryker (NYSE:SYK) will participate in the 6th Annual Evercore ISI HealthCONx Conference on Wednesday, November 29, 2023 at the Kimpton EPIC Hotel in Miami, Florida. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice...
Oct 12, 2023 08:35 am ET
Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today that its Q Guidance System with Spine Guidance Software has been used to deliver enhanced surgical planning and navigation in over 2,400 spinal cases. The Q Guidance System for both spine and cranial applications will be featured at the Nor
Oct 09, 2023 04:05 pm ET
Stryker to host investor day
Stryker (NYSE:SYK) announced that it will host an Investor Day on Wednesday, November 8, 2023, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's...
Oct 02, 2023 04:05 pm ET
Stryker to announce financial results for its third quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for third quarter of fiscal year 2023 on Thursday, November 2, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
Sep 21, 2023 02:07 pm ET
Stryker's Triathlon Tritanium Baseplate marks a decade of positive patient impact
Over 1 million Triathlon Cementless Knees implanted globally
Sep 19, 2023 09:20 am ET
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint. The system will debut at the
Sep 14, 2023 08:03 am ET
A Clearer Vision of Surgery: Stryker Releases its Next-Generation of Advanced Surgical Cameras
Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities
Sep 12, 2023 09:20 am ET
Stryker’s Pangea Systems Receive FDA Clearance
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration.
Aug 07, 2023 04:05 pm ET
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will...
Aug 03, 2023 04:05 pm ET
Stryker reports second quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billionOrganic net sales increased 11.9%Reported operating income margin of 19.3%Adjusted...
Aug 02, 2023 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable October 31, 2023 to shareholders of record at the close of business on September 29, 2023, representing an increase of 7.9% versus...
Jul 11, 2023 08:30 am ET
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
Stryker (NYSE: SYK), one of the world’s leading medical technology companies, has commercially launched its Q Guidance System with Cranial Guidance Software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery. The software can be used
Jul 06, 2023 08:27 am ET
Stryker launches industry's only fully autonomous guidance system
Ortho Q Guidance system with Ortho Guidance software offers state-of-the-art workflow
Jun 30, 2023 04:05 pm ET
Stryker to announce financial results for its second quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for second quarter of fiscal year 2023 on Thursday, August 3, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day....
May 24, 2023 08:30 am ET
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries.
May 10, 2023 01:01 pm ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the...
May 02, 2023 08:00 am ET
Stryker completes acquisition of Cerus Endovascular
KALAMAZOO, Michigan, USA, May 2, 2023 /PRNewswire/ -- Stryker (NYSE:SYK), one of the world's leading medical technology companies, announced today that it has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage, medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms. Cerus Endovascular's CE Marked products, the Contour Neurovascular System and the Neqstent Coil Assisted Flow Diverter, will expand Stryker's current portfolio of aneurysm treatment solutions.
May 01, 2023 04:05 pm ET
Stryker reports first quarter 2023 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2023: First Quarter Results Reported net sales increased 11.8% to $4.8 billionOrganic net sales increased 13.6%Reported operating income margin of 15.4%Adjusted operating...
Mar 30, 2023 04:05 pm ET
Stryker to announce financial results for its first quarter of fiscal year 2023
Stryker (NYSE:SYK) announced that it will report financial results for first quarter of fiscal year 2023 on Monday, May 1, 2023.  A press release will be issued at approximately 4:05pm ET and available at Stryker - Press Releases that day. The...
Mar 30, 2023 08:27 am ET
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that Armodios M. Hatzidakis, MD, FAAOS, Western Orthopaedics, PC, Denver Surgery Center and Rose Medical Center, has successfully completed the first case in the United States, since the De Novo clearance, using the Tornier Pyrocarbon Humeral Head. Stryker’s De Novo request was granted in late 2022 after completing an Investigational Device Exemption (IDE) study with the FDA.
Mar 28, 2023 01:12 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2023 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 10, 2023 – 9:00 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will...
Feb 17, 2023 09:30 am ET
Stryker’s Q Guidance System for cranial applications receives FDA clearance
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative guidance system designed to support cranial surgeries. Recently
Feb 09, 2023 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable April 28, 2023 to shareholders of record at the close of business on March 31, 2023, representing an increase of 7.9% versus the...
Feb 01, 2023 08:34 am ET
Thinking about trading options or stock in Meta, Baidu, Apple, Stryker, or NVIDIA?
NEW YORK, Feb. 1, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for META, BIDU, AAPL, SYK, and NVDA.
Jan 31, 2023 04:05 pm ET
Stryker reports 2022 operating results and 2023 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2022: Fourth Quarter Results Reported net sales increased 10.7% to $5.2 billionOrganic net sales increased 13.2%Reported operating income margin of...
Dec 28, 2022 04:05 pm ET
Stryker to host conference call on January 31, 2023
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 31, 2023 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending December 31, 2022 and provide an operational update. Final...
Dec 13, 2022 10:27 am ET
Stryker launches Citrefix™ Suture Anchor System, featuring award-winning Citregen biomaterial designed to support bone regeneration and the natural healing process
Stryker (NYSE:SYK) today announced the launch of Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system uses Citregen™, an award-winning bioresorbable material designed to mimic the chemistry and structure of native bone.1
Dec 07, 2022 08:00 am ET
Stryker declares a $0.75 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable January 31, 2023 to shareholders of record at the close of business on December 30, 2022, representing an increase of  7.9% versus...
Nov 14, 2022 06:00 am ET
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
This operating room model puts increased focus on design for patient and staff safety, productivity and operational efficiency—further enabling improvements in quality of care
Nov 03, 2022 04:05 pm ET
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
Stryker (NYSE:SYK) will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022. Kevin Lobo, Chair and Chief Executive Officer and Jason Beach, Vice President, Investor Relations will represent the Company...
Oct 31, 2022 04:05 pm ET
Stryker reports third quarter 2022 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2022: Third Quarter Results Reported net sales increased 7.7% to $4.5 billionOrganic net sales increased 9.9%Reported operating income...
Oct 12, 2022 08:45 am ET
Stryker to Showcase Innovative Portfolio of Spine Solutions at the North American Spine Society Meeting
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, will feature its suite of procedural solutions for spinal surgery, including its award-winning Q Guidance System with Spine Guidance Software, during the North American Spine Society (NASS) annual meeting in Chicago, Oct. 12–15 (booth #4211).
Oct 04, 2022 08:45 am ET
Stryker Launches Monterey AL Interbody System with New Pre-clinical Data
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of the Monterey AL Interbody System, a stand-alone interbody fusion device designed for anterior lumbar interbody fusion (ALIF). Monterey AL is made up of both solid and porous structures within a single implant, leveraging Stryker’s proprietary Tritanium In-Growth Technology, a material designed to mimic cancellous bone and provide an environment favorable to bone regeneration and fusion.1-4 New data demonstrates that undifferentiated stem cells grown on Tritanium exhibited osteo
Sep 29, 2022 04:05 pm ET
Stryker to host conference call on October 31, 2022
Stryker (NYSE:SYK) announced that it will host a conference call on Monday, October 31, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ending September 30, 2022 and provide an operational update. Final...
Sep 27, 2022 08:45 am ET
Stryker Launches Q Guidance System with Spine Guidance Software
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today the launch of its Q Guidance System for spine applications. The System combines new optical tracking options provided by a redesigned, state-of-the-art camera with sophisticated algorithms of the newly launched Spine Guidance Software to deliver more surgical planning and navigation capability than ever before. When used with the Q Guidance System, the Spine Guidance Software is intended as a planning and intraoperative guidance system to enable open or percutaneous computer-assisted surgery and is the
Sep 20, 2022 08:07 am ET
Stryker receives FDA clearance for OptaBlate™ Bone Tumor Ablation System
Stryker's first bone tumor ablation system with patented microinfusion technology offers a reliable solution for people living with painful metastatic tumors
Sep 14, 2022 08:05 am ET
Stryker Launches Pulse Intelligent Delivery Platform at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting
Stryker (NYSE:SYK) today announced the launch of its Pulse Intelligent Delivery Platform, a full-circle product and fulfillment offering optimized for high volume foot and ankle procedures in the ambulatory surgery center (ASC) setting, which will debut at the 2022 American Orthopaedic Foot & Ankle Society Annual Meeting (AOFAS), taking place Sept. 14-17 in Québec City, Canada. The company will also feature its Prophecy® Footprint Surgical Planning, which will be the first surgical planning tool to provide clinical guidance on the whole foot in connection with total ankle arthroplas
Sep 01, 2022 08:07 am ET
Stryker Launches New Gamma4 Hip Fracture Nailing System
Stryker (NYSE:SYK) has launched the Gamma4 System, strengthening the product’s 30-year legacy of continuous innovation and clinical history. The newest Gamma System will provide surgeons with the next generation of Stryker’s intramedullary nailing system.
Aug 22, 2022 04:05 pm ET
Stryker to participate in the 2022 Wells Fargo Securities Healthcare Conference
Stryker (NYSE:SYK) will participate in the 2022 Wells Fargo Securities Healthcare Conference on Thursday, September 8, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer and Jason Beach, Vice President, Investor Relations will...
Aug 03, 2022 08:00 am ET
Stryker declares a $0.695 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable October 31, 2022 to shareholders of record at the close of business on September 30, 2022, representing an increase of 10.3%...
Jul 26, 2022 04:05 pm ET
Stryker reports second quarter 2022 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2022: Second Quarter Results Reported net sales increased 4.6% to $4.5 billionOrganic net sales increased 6.1%Reported...
Jun 30, 2022 10:04 am ET
Stryker to host conference call on July 26, 2022
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 26, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2022 and provide an operational update. Final operating...
Jun 28, 2022 08:33 am ET
Stryker Launches “Free Your Feet” Campaign to Raise Awareness About New Bunion Treatments
Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today launched an experiential campaign to inspire consumers to explore new treatment options for bunions and increase awareness of the benefits of bunion surgery. The interactive campaign consists of visually creative chalk designs in four major metropolitan cities – New York City, Los Angeles, Chicago and Miami – prompting passersby to learn more.
Jun 24, 2022 11:00 am ET
Stryker's debut at World Intelligence Congress: Bringing Stryker's Advanced Digital Healthcare to China
SHANGHAI, June 24, 2022 /PRNewswire/ -- Stryker (NYSE:SYK), a leading medical technologies company, attended the 6th World Intelligence Congress (WIC) in China, showcasing how its Advanced Digital Healthcare solutions brings clinical, operational and financial values for the healthcare market. This is the first time for Stryker to participate in WIC as a strategic partner in healthcare industry, marking a significant milestone for Stryker as it brings more Advanced Digital Healthcare solutions to the China market.
May 31, 2022 08:59 am ET
Stryker Receives FDA Clearance for Q Guidance System for Spine Applications
Stryker (NYSE:SYK) today announced that its Q Guidance System received 510(k) clearance from the U.S. Food and Drug Administration. The System, when used with the Spine Guidance Software, is an advanced planning and intraoperative guidance system designed to enable open or percutaneous computer-assisted surgery. The Spine Guidance Software is the first spine navigation software to receive clearance from the FDA for use with pediatric patients aged 13 and older.
May 12, 2022 01:00 pm ET
AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors
AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq: AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life...
May 05, 2022 12:00 pm ET
Stryker announces new Investor Relations leader
Stryker (NYSE:SYK) announced today that Jason Beach will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective July 1, 2022. Preston Wells, Vice President, Investor Relations...
May 05, 2022 08:00 am ET
Stryker announces board changes following Annual Meeting of Shareholders
Stryker (NYSE: SYK) announced that on May 4, 2022, the company’s board of directors approved board leadership and committee assignment changes, naming Sherilyn S. McCoy to replace Allan C. Golston as Lead Independent Director, and Mary K. Brainerd...
May 04, 2022 08:00 am ET
Stryker declares a $0.695 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable July 29, 2022 to shareholders of record at the close of business on June 30, 2022, representing an increase of 10.3% versus the...
May 03, 2022 06:59 am ET
Stryker's InSpace subacromial balloon spacer two-year, Level 1 randomized controlled clinical study published in the Journal of Bone and Joint Surgery
InSpace implant demonstrated to be a viable option for patients with massive irreparable rotator cuff tears.*
May 02, 2022 04:05 pm ET
Stryker to participate in the Bank of America Securities 2022 Health Care Conference
Stryker (NYSE:SYK) will participate in the Bank of America Securities 2022 Health Care Conference on Wednesday, May 11, 2022. Andy Pierce, Group President, MedSurg and Neurotechnology and Preston Wells, Vice President, Investor Relations will...
Apr 28, 2022 04:05 pm ET
Stryker reports first quarter 2022 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2022: First Quarter Results Reported net sales increased 8.1% to $4.3 billionOrganic net sales increased 9.2%Reported operating income margin of 10.5%Adjusted...
Apr 20, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating Mullen, Stryker, and CIRCOR and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Mullen Automotive, Inc. (NASDAQ: MULN), Stryker Corporation (NYSE: SYK), and CIRCOR International, Inc. (NYSE: CIR). Our...
Apr 15, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Is Investigating CIRCOR, NeoGenomics, Stryker, and Mullen and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CIRCOR International, Inc. (NYSE: CIR), NeoGenomics, Inc. (NASDAQ: NEO), Stryker Corporation (NYSE: SYK), and Mullen...
Apr 10, 2022 09:00 pm ET
STRYKER ALERT: Bragar Eagel & Squire, P.C. is Investigating Stryker Corporation on Behalf of Stryker Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) on behalf of Stryker stockholders. Our investigation concerns whether Stryker has violated the federal securities laws and/or engaged in other unlawful business practices.
Apr 08, 2022 09:00 pm ET
STRYKER ALERT: Bragar Eagel & Squire, P.C. is Investigating Stryker Corporation on Behalf of Stryker Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) on behalf of Stryker stockholders. Our investigation concerns whether Stryker has violated the federal securities laws and/or engaged in other unlawful business practices.
Apr 07, 2022 08:44 pm ET
Investigation Alert: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Stryker Corporation (NYSE: SYK) Investors
The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Stryker Corporation (NYSE: SYK) (Stryker). Stryker is a medical technology...
Apr 06, 2022 11:51 am ET
(SYK) NEWS: Did You Lose Money on Your Stryker Investment? Contact Johnson Fistel Regarding Investigation
Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Stryker Corporation (NYSE: SYK). What is Johnson Fistel investigating? On April 6, 2022, Spruce Point Capital Management, LLC...
Apr 06, 2022 10:01 am ET
SYK Alert: Monsey Firm of Wohl & Fruchter LLP Investigating Stryker Corporation for Potential Securities Law Violations
The law firm of Wohl & Fruchter LLP is investigating whether Stryker Corporation (NYSE: SYK) (“Stryker”) has violated federal securities laws. If you suffered losses as a result of today’s drop in the price of SYK, and have questions about your...
Mar 30, 2022 09:31 am ET
Thinking about trading options or stock in Paychex, Apple, NVIDIA, Deere & Company, or Stryker Corp?
NEW YORK, March 30, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PAYX, AAPL, NVDA, DE, and SYK.
Mar 30, 2022 09:00 am ET
Stryker to host conference call on April 28, 2022
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 28, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2022 and provide an operational update.Final...
Mar 24, 2022 03:10 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2022 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 4, 2022 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which...
Feb 25, 2022 04:30 pm ET
Vocera Communications, Inc. Announces Fundamental Change and Make-Whole Fundamental Change With Respect to its 1.50% Convertible Senior Notes due 2023 and 0.50% Convertible Senior Notes due 2026
Vocera Communications, Inc., a recognized leader in clinical communication and workflow solutions, today announced that, in connection with the recently announced completion of its acquisition (the “Acquisition”) by Stryker Corporation (NYSE: SYK), a Fundamental Change and Make-Whole Fundamental Change has occurred under the indentures go
Feb 23, 2022 08:30 am ET
Stryker completes acquisition of Vocera Communications
Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Vocera Communications, Inc. (NYSE: VCRA), a leader in digital care coordination and communication. “This acquisition provides significant...
Feb 15, 2022 11:30 am ET
Stryker to participate in Cowen 42nd Annual Health Care Conference
Stryker (NYSE:SYK) will participate in the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022. Glenn Boehnlein, Vice President, Chief Financial Officer, will represent the Company in a virtual presentation scheduled for 10:30 a.m....
Feb 02, 2022 08:00 am ET
Stryker declares a $0.695 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable April 29, 2022 to shareholders of record at the close of business on March 31, 2022, representing an increase of 10.3% versus the...
Jan 27, 2022 04:05 pm ET
Stryker reports 2021 operating results and 2022 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2021: Fourth Quarter Results Reported net sales increased 10.3% from 2020...
Jan 25, 2022 06:30 am ET
Stryker commences tender offer for all outstanding shares of common stock of Vocera Communications
Stryker (NYSE:SYK) today announced that it is commencing, through a wholly owned subsidiary, Voice Merger Sub Corp., a cash tender offer to purchase all outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per...
Jan 10, 2022 05:16 pm ET
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Lawson Products, Inc. (Nasdaq - LAWS), Enterprise Diversifi
Brodsky & Smith reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you...
Jan 07, 2022 08:25 pm ET
VOCERA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vocera Communications, Inc. - VCRA
NEW ORLEANS, Jan. 7, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Vocera Communications, Inc. (NYSE: VCRA) to Stryker (NYSE: SYK).  Under the terms of the proposed transaction, shareholders of Vocera will receive only $79.25 in cash for each share of Vocera that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Jan 07, 2022 12:59 pm ET
VOCERA ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of VCRA and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Vocera Communications, Inc. (NYSE: VCRA) breached their fiduciary duties or violated the...
Jan 06, 2022 09:11 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Investigates Vocera Communications, Inc.
NEW YORK, Jan. 6, 2022 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vocera Communications, Inc. ("Vocera" or the "Company") (NYSE: VCRA), in connection with the proposed acquisition of the Company by Stryker Corporation ("Stryker") (NYSE: SYK) via a tender offer.  Under the terms of the acquisition agreement, the Company's shareholders will receive $79.25 per share in cash for each share of Vocera common stock that they hold.  The transaction is valued at approximately $3.09 billion.
Jan 06, 2022 08:06 am ET
Stryker announces definitive agreement to acquire Vocera Communications
Stryker (NYSE: SYK) announced today a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. (NYSE: VCRA) for $79.25 per share, or a total equity value of approximately $2.97...
Jan 05, 2022 11:30 am ET
Stryker to host conference call on January 27, 2022
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, January 27, 2022 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2021 and provide an operational update. Final...
Dec 09, 2021 08:00 am ET
Stryker declares a $0.695 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.695 per share payable January 31, 2022 to shareholders of record at the close of business on December 31, 2021, representing an increase of 10.3%...
Dec 09, 2021 06:17 am ET
ENT Practice Milton Hall Surgical Associates, LLC, Jeffrey M. Gallups, M.D. and Entellus Medical, Inc. Agree to Pay $4,200,000 to Settle Whistleblower Allegations of Medically Unnecessary Genetic and
ATLANTA, Dec. 9, 2021 /PRNewswire/ -- Atlanta- and New York-based Moss & Gilmore LLP announced today the settlement with the U.S. Department of Justice ("DOJ") and State of Georgia of a False Claims Act ("FCA") lawsuit against Defendants Jeffrey M. Gallups, M.D. ("Dr. Gallups"), Milton Hall Surgical Associates, LLC ("MHSA") and Entellus Medical, Inc. on behalf of its client, Dr. Myron Jones, an ear, nose and throat doctor and a board certified otolaryngologist. Dr. Jones is a former Army Colonel and Active Duty U.S. Army Otolaryngologist who has been practicing medicine for over thirty f
Oct 28, 2021 04:05 pm ET
Stryker reports third quarter 2021 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2021: Third Quarter Results Reported net sales increased 11.3% from 2020 and 16.0% from 2019 to $4.2 billionOrganic net sales increased 4.5% from 2020 and...
Oct 11, 2021 11:00 am ET
Stryker to host analyst meeting
Stryker (NYSE:SYK) announced that it will host an Analyst Meeting on Thursday, November 18, 2021, at 2:30 p.m. Eastern Time, in Mahwah, New Jersey. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's...
Sep 23, 2021 11:30 am ET
Stryker to host conference call on October 28, 2021
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 28, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2021 and provide an operational update. Final...
Sep 01, 2021 08:15 pm ET
Stuart F. Simpson is THINK Surgical's New President and Chief Executive Officer
FREMONT, Calif., Sept. 1, 2021 /PRNewswire/ -- THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced the appointment of Stuart F. Simpson as its president and chief executive officer. Mr. Simpson's decades of experience in the medical device industry, particularly his deep understanding of the orthopedics industry and orthopedic surgical robots, makes him the ideal person to lead THINK Surgical. 
Aug 30, 2021 08:30 am ET
Stryker to participate in Morgan Stanley’s 19th Annual Global Healthcare Conference
Stryker (NYSE:SYK) will participate in Morgan Stanley’s 19th Annual Global Healthcare Conference on Monday, September 13, 2021. Kevin Lobo, Chair and Chief Executive Officer, will represent the Company in a virtual presentation scheduled for...
Aug 18, 2021 08:00 am ET
Stryker President and COO Timothy J. Scannell to retire
Stryker (NYSE:SYK) announced today that after an outstanding thirty-one-year career at Stryker, Timothy J. Scannell, President and Chief Operating Officer has notified the company of his intent to retire on March 31, 2023. Effective October 1, 2021...
Aug 04, 2021 08:00 am ET
Stryker declares a $0.63 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable October 29, 2021 to shareholders of record at the close of business on September 30, 2021, representing an increase of 9.6% versus...
Jul 27, 2021 04:05 pm ET
Stryker reports second quarter 2021 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2021: Second Quarter Results Reported net sales increased 55.4% from 2020 and 17.6% from 2019 to $4.3 billionOrganic net sales increased 42.9%...
Jun 24, 2021 02:00 pm ET
Stryker to host conference call on July 27, 2021
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2021 and provide an operational update. Final operating...
May 04, 2021 04:05 pm ET
Stryker declares a $0.63 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of record at the close of business on June 30, 2021, representing an increase of 9.6% versus the...
Apr 27, 2021 04:05 pm ET
Stryker reports first quarter 2021 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2021: The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governments and health care authorities globally, including the...
Apr 26, 2021 10:00 am ET
Stryker to participate in the Bank of America Securities 2021 Virtual Health Care Conference
Stryker (NYSE:SYK) will participate in the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. Spencer Stiles, Group President, Orthopaedics & Spine, Robert Cohen, President, Digital, Robotics and Enabling...
Mar 29, 2021 02:30 pm ET
Stryker to host conference call on April 27, 2021
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2021 and provide an operational update. Final...
Mar 24, 2021 03:00 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2021 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 5, 2021 – 2:00 p.m. Eastern Time Due to concerns regarding the coronavirus outbreak (“COVID-19”) and to assist in protecting the...
Feb 17, 2021 02:00 pm ET
Stryker to participate in the 41st Annual Cowen Health Care Conference
Stryker (NYSE:SYK) will participate in the 41st Annual Cowen Health Care Conference on Tuesday, March 2, 2021. Preston Wells, Vice President, Investor Relations and Andy Pierce, Group President, MedSurg & Neurotechnology, will represent the...
Feb 09, 2021 07:30 am ET
Nextech AR’s Virtual Event Platform Selected by Canadian Surgery Forum for Its 2021 Virtual Trade Show
Nextech AR Solutions (Nextech) (OTCQB: NEXCF) (NEO: NTAR.NE) (CSE:NTAR) (FSE: N29), a diversified leading provider of augmented reality (AR), virtual event live streaming experiences plus services for 3D ads, eCommerce, and education, today...
Feb 02, 2021 04:05 pm ET
Stryker declares a $0.63 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable April 30, 2021 to shareholders of record at the close of business on March 31, 2021, representing an increase of 9.6% versus the...
Jan 27, 2021 04:05 pm ET
Stryker reports 2020 operating results and 2021 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2020 and 2021 outlook: The response to the COVID-19 pandemic has included measures to slow the spread of the virus taken by governments and health care...
Jan 05, 2021 08:00 am ET
Stryker acquires OrthoSensor
Stryker (NYSE:SYK) announced today the acquisition of OrthoSensor, Inc., a privately held company founded in 2007 and headquartered in Dania Beach, FL. OrthoSensor, Inc., is a leader in the digital evolution of musculoskeletal care and sensor...
Jan 04, 2021 02:00 pm ET
Stryker to host conference call on January 27, 2021
Stryker (NYSE:SYK) announced that it will host a conference call on Wednesday, January 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2020 and provide an operational update. Final...
Dec 02, 2020 04:05 pm ET
Stryker declares a $0.63 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable January 29, 2021 to shareholders of record at the close of business on December 31, 2020, representing an increase of 9.6% versus...
Nov 18, 2020 05:00 pm ET
Stryker announces pricing of $600 million senior notes offering
Stryker (NYSE:SYK) (the “Company”) announced today that it has priced an offering of $600 million aggregate principal amount of its 0.600% Notes due 2023 (the “Notes”). Unless previously redeemed pursuant to their terms, the Notes will mature on...
Nov 17, 2020 09:30 am ET
Stryker to participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference
Stryker (NYSE:SYK) will participate in the 3rd Annual Evercore ISI HealthCONx Virtual Conference on Thursday, December 3, 2020. Preston Wells, Vice President, Investor Relations and Spencer Stiles, Group President, Orthopaedics and Spine, will...
Nov 11, 2020 07:45 am ET
Stryker completes acquisition of Wright Medical
Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics. “This acquisition enhances our...
Nov 10, 2020 09:15 pm ET
Stryker announces intention to complete acquisition of Wright Medical
Stryker (NYSE: SYK) announced today that it intends to complete the acquisition of Wright Medical Group N.V. (NASDAQ: WMGI) by effectuating the mergers described in the tender offer statement on Schedule TO filed by Stryker B.V., an indirect,...
Nov 09, 2020 07:30 am ET
Stryker elects Giovanni Caforio to Board of Directors
Stryker (NYSE:SYK) announced today that Giovanni Caforio, M.D., Chairman and Chief Executive Officer of Bristol Myers Squibb, has been elected to its Board of Directors, effective December 1, 2020.  “Giovanni adds extensive experience to our board...
Nov 04, 2020 07:30 am ET
Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical
Stryker (NYSE: SYK) announced today that all required regulatory approvals have been obtained for the previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) by Stryker B.V., an...
Oct 29, 2020 04:05 pm ET
Stryker reports third quarter 2020 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities...
Oct 26, 2020 07:30 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Oct 13, 2020 07:30 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Sep 29, 2020 07:30 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Sep 28, 2020 02:00 pm ET
Stryker to host conference call on October 29, 2020
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 29, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2020 and provide an operational update. Final...
Sep 02, 2020 01:00 pm ET
Stryker to participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference
Stryker (NYSE:SYK) will participate in the Morgan Stanley 18th Annual Virtual Global Healthcare Conference on Tuesday, September 15, 2020. Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a presentation scheduled...
Aug 28, 2020 07:30 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Jul 30, 2020 04:05 pm ET
Stryker reports second quarter 2020 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities...
Jul 30, 2020 08:00 am ET
Stryker declares a $0.575 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable October 30, 2020 to shareholders of record at the close of business on September 30, 2020, representing an increase of...
Jun 29, 2020 07:30 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Jun 25, 2020 09:30 am ET
Stryker to host conference call on July 30, 2020
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2020 and provide an operational update. Final...
May 26, 2020 05:45 pm ET
Stryker announces pricing of $2.3 billion senior notes offering
Stryker (NYSE:SYK) (the “Company”) announced today that it has priced the following senior notes: (i) $650 million aggregate principal amount of the Company’s 1.150% Notes due 2025 (the “2025 Notes”), (ii) $1 billion aggregate principal amount of...
May 26, 2020 04:15 pm ET
RTI Surgical Holdings, Inc.® Appoints Stuart F. Simpson to Board of Directors
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced the appointment of Stuart F. Simpson as an independent member of its board of directors. Mr. Simpson most recently served as the President of the Joint...
May 05, 2020 08:00 am ET
Stryker declares a $0.575 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on July 31, 2020 to shareholders of record at the close of business on June 30, 2020, representing an increase of approximately...
Apr 30, 2020 04:05 pm ET
Stryker reports first quarter 2020 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2020: The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally,...
Apr 27, 2020 07:45 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Apr 17, 2020 07:14 pm ET
BetterInvesting Magazine Releases June "Stock To Study" And "Undervalued Stock" Choices For Investors' Informational And Educational Use
MADISON HEIGHTS, Mich., April 17, 2020 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Stryker Corporation (NYSE: SYK) as its June 2020 "Stock to Study" and Ulta Beauty, Inc. (NASDAQ: ULTA) as its June 2020 "Undervalued Stock" for investors' informational and educational use.
Apr 09, 2020 10:30 am ET
Stryker to host conference call on April 30, 2020
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, April 30, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2020 and provide an operational update. Final...
Mar 24, 2020 10:00 am ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2020 Annual Meeting of Shareholders is scheduled as follows: May 5, 2020 – 2:00 p.m. Eastern Time Due to concerns regarding the coronavirus outbreak and to assist in protecting the health and well-being of our...
Mar 02, 2020 08:00 am ET
Stryker announces new Investor Relations leader
Stryker (NYSE:SYK) announced today that Preston Wells will be appointed Vice President, Investor Relations and report to Glenn Boehnlein, the company’s Chief Financial Officer, effective June 1, 2020. After a very successful thirteen-year period,...
Feb 26, 2020 08:00 am ET
Stryker extends cash tender offer for all outstanding shares of Wright Medical
Stryker (NYSE: SYK) announced today that Stryker B.V., an indirect, wholly owned subsidiary of Stryker, has extended the offering period of its previously announced cash tender offer for all outstanding ordinary shares of Wright Medical Group N.V....
Feb 25, 2020 02:00 pm ET
Stryker to participate in Cowen 40th Annual Health Care Conference
Stryker (NYSE:SYK) ) will participate in the Cowen 40th Annual Health Care Conference on Tuesday, March 3, 2020 at the Boston Marriott Copley Place in Boston, Massachusetts.  Katherine Owen, Vice President, Strategy & Investor Relations, will...
Feb 25, 2020 08:08 am ET
Stryker announces nomination of new Director, Lisa Skeete Tatum
Stryker (NYSE:SYK) announced that Lisa Skeete Tatum has been nominated for election to the company’s Board of Directors at Stryker’s 2020 Annual Meeting of Shareholders, which will be held on May 5, 2020. Ms. Skeete Tatum is the Founder and...
Feb 18, 2020 08:15 am ET
Stryker named to the 100 Best Companies to Work For list for 10th consecutive year
Kalamazoo, Michigan – February 18, 2020 – Stryker (NYSE:SYK), one of the world’s leading medical technology companies, announced today it has been named one of Fortune’s 2020 100 Best Companies to Work For in its annual survey and evaluation of...
Feb 12, 2020 09:00 am ET
SHAREHOLDER ALERT: WeissLaw LLP Reminds WMGI Shareholders of Its Ongoing Investigation.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Wright Medical Group N.V. (“WMGI” or the “Company”) (NASDAQ: WMGI) in connection with the proposed acquisition of the Company...
Feb 05, 2020 02:00 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Reminds WMGI Shareholder of Its Ongoing Investigation
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Wright Medical Group N.V. (“WMGI” or the “Company”) (NASDAQ: WMGI) in connection with the proposed acquisition of the Company...
Feb 05, 2020 08:00 am ET
Stryker declares a $0.575 per share quarterly dividend
Kalamazoo, Michigan – February 5, 2020 – Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on April 30, 2020 to shareholders of record at the close of business on March 31, 2020,...
Jan 31, 2020 03:16 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Reminds WMGI Shareholders of Its Ongoing Investigation
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Wright Medical Group N.V. (“WMGI” or the “Company”) (NASDAQ: WMGI) in connection with the proposed acquisition of the Company...
Jan 28, 2020 04:05 pm ET
Stryker reports 2019 results and 2020 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2019 and 2020 outlook: Fourth Quarter Highlights Reported net sales increased 8.8% to $4.1 billionOrganic net sales increased 8.0%Reported operating...
Jan 06, 2020 01:45 pm ET
Stryker to host conference call on January 28, 2020
Kalamazoo, Michigan – January 6, 2020 – Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 28, 2020 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2019 and...
Dec 04, 2019 03:00 pm ET
Stryker increases dividend 11%, declaring a $0.575 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.575 per share payable on January 31, 2020 to shareholders of record at the close of business on December 31, 2019, representing an increase of...
Nov 25, 2019 03:16 pm ET
Stryker announces pricing of €2.4 billion senior notes offering
Stryker (NYSE:SYK) announced today that it has priced the following senior notes: (i) €850 million aggregate principal amount of the Company’s 0.25% Notes due 2024 (the “2024 Notes”), (ii) €800 million aggregate principal amount of the Company’s...
Nov 04, 2019 12:30 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Wright Medical Group N.V. to Stryker Corporation is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Wright Medical Group N.V. (“Wright” or the “Company”) (NASDAQ: WMGI) stock prior to November 4, 2019. You are hereby notified that Levi &...
Nov 04, 2019 07:00 am ET
Stryker announces definitive agreement to acquire Wright Medical
Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a...
Nov 04, 2019 07:00 am ET
Wright Medical Group N.V. Announces Definitive Agreement to be Acquired by Stryker
Wright Medical Group N.V. (NASDAQ: WMGI) today announced that it has entered into a definitive agreement under which Stryker (NYSE: SYK) will acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for a total equity...
Oct 29, 2019 04:05 pm ET
Stryker reports third quarter 2019 operating results
Stryker (NYSE:SYK) reported operating results for the third quarter of 2019: Third Quarter Highlights Reported net sales increased 10.6% to $3.6 billionOrganic net sales increased 8.6%Reported operating income margin of...
Oct 21, 2019 08:05 am ET
Stryker completes acquisition of Mobius Imaging and Cardan Robotics
Stryker (NYSE: SYK) announced today it has completed the acquisition of Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics). “Mobius Imaging and Cardan Robotics bring...
Sep 25, 2019 01:00 pm ET
Stryker to host conference call on October 29, 2019
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, October 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended September 30, 2019 and provide an operational update. Final...
Sep 04, 2019 08:00 am ET
Stryker announces definitive agreement to acquire Mobius Imaging & Cardan Robotics
Stryker (NYSE: SYK) announced today a definitive agreement to acquire Mobius Imaging, LLC, a leader in point-of-care imaging technology, and its sister company, GYS Tech, LLC (DBA Cardan Robotics), in an all cash transaction of approximately $370...
Aug 21, 2019 10:35 am ET
Stryker to participate in Morgan Stanley 17th Annual Global Healthcare Conference
Stryker (NYSE:SYK) ) will participate in the Morgan Stanley 17th Annual Global Healthcare Conference on Tuesday, September 10, 2019 at the Grand Hyatt New York.  Kevin Lobo, Chairman and Chief Executive Officer, will represent the Company in a...
Aug 12, 2019 04:00 pm ET
Stryker announces commercial structure realignment
Stryker (NYSE:SYK) announced today an adjustment to its commercial organizational structure. Spencer S. Stiles will serve as Group President of Orthopaedics and Spine and will oversee Stryker’s Joint Replacement, Trauma & Extremities and Spine...
Jul 31, 2019 08:15 am ET
Stryker declares a $0.52 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on October 31, 2019 to shareholders of record at the close of business on September 30, 2019, representing an increase of...
Jul 25, 2019 04:07 pm ET
Stryker reports second quarter 2019 operating results
Stryker (NYSE:SYK) reported operating results for the second quarter of 2019: Second Quarter Highlights Reported net sales increased 9.9% to $3.7 billionOrganic net sales increased 8.5%Reported operating income margin of 16.8%Adjusted...
Jun 24, 2019 02:30 pm ET
Stryker to host conference call on July 25, 2019
Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 25, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended June 30, 2019 and provide an operational update. Final...
May 01, 2019 03:00 pm ET
Stryker to participate in Bank of America Merrill Lynch 2019 Health Care Conference
Stryker (NYSE:SYK) will participate in the Bank of America Merrill Lynch 2019 Health Care Conference on Tuesday, May 14, 2019 at the Encore at Wynn Hotel in Las Vegas, Nevada.   Glenn Boehnlein, Vice President and Chief Financial Officer, will...
May 01, 2019 08:00 am ET
Stryker declares a $0.52 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on July 31, 2019 to shareholders of record at the close of business on June 28, 2019, representing an increase of approximately...
Apr 23, 2019 04:05 pm ET
Stryker reports first quarter 2019 operating results
Stryker (NYSE:SYK) reported operating results for the first quarter of 2019: First Quarter Highlights Reported net sales increased 8.5% to $3.5 billionOrganic net sales increased 7.3%Reported operating income margin of...
Mar 27, 2019 04:01 pm ET
Stryker announces new Vice President, Chief Legal Officer
Stryker (NYSE:SYK) announced today that Rob Fletcher will be joining the company as Vice President, Chief Legal Officer effective April 22, 2019. Mike Hutchinson will be transitioning from his current role to serve as Advisor to the Chief Executive...
Mar 21, 2019 01:00 pm ET
Stryker to host conference call on April 23, 2019
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, April 23, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended March 31, 2019 and provide an operational update. Final...
Mar 20, 2019 02:30 pm ET
Stryker announces Annual Meeting of Shareholders
Stryker (NYSE:SYK) announced its 2019 Annual Meeting of Shareholders is scheduled as follows: May 1, 2019 – 2:00 p.m. Eastern TimeRadisson Plaza Hotel & Suites at The Kalamazoo CenterKalamazoo, Michigan                Information about the...
Mar 14, 2019 08:00 am ET
Stryker acquires OrthoSpace, Ltd.
Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, Israel, in an all cash transaction for an upfront payment of $110 million and future...
Mar 04, 2019 07:35 am ET
Analysis: Positioning to Benefit within eBay, Ingersoll-Rand PLC (Ireland), BJ's Restaurants, Stryker, FLIR, and Verisk Analytics — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of eBay Inc. (NASDAQ:EBAY), Ingersoll-Rand PLC (Ireland) (NYSE:IR), BJ's...
Feb 25, 2019 04:05 pm ET
Stryker acquires Arrinex
Stryker (NYSE:SYK) announced today it has completed the acquisition of Arrinex, Inc., a medical device company headquartered in Menlo Park, California, that has developed ClariFix®, a novel cryoablation technology for the treatment of chronic...
Feb 14, 2019 08:15 am ET
Fortune Magazine names Stryker one of the 100 Best Companies to Work For in 9th consecutive year
Kalamazoo, Michigan – February 14, 2019 – Stryker (NYSE:SYK) announced today it has been named one of Fortune’s 2019 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States. The list...
Feb 12, 2019 02:00 pm ET
Stryker to participate in 8th Annual Leerink Partners Global Healthcare Conference
Stryker (NYSE:SYK) will participate in the 8th Annual Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019 at the Lotte New York Palace in New York, New York. Katherine Owen, Vice President, Strategy and Investor...
Feb 06, 2019 08:01 am ET
Stryker declares a $0.52 per share quarterly dividend
Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on April 30, 2019 to shareholders of record at the close of business on March 29, 2019, representing an increase of approximately...
Jan 31, 2019 08:15 am ET
Research Report Identifies Stryker, Total System Services, Vista Outdoor, Plains All American Pipeline, Emerson Electric, and IZEA with Renewed Outlook — Fundamental Analysis, Calculating Forward Move
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Stryker Corporation (NYSE:SYK), Total System Services, Inc. (NYSE:TSS),...
Jan 29, 2019 04:06 pm ET
Stryker reports 2018 results and 2019 outlook
Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2018 and 2019 outlook: Fourth Quarter Highlights •       Reported net sales increased 9.4% to $3.8 billion...
Jan 04, 2019 02:30 pm ET
Stryker to host conference call on January 29, 2019
Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, January 29, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results for the quarter ended December 31, 2018 and provide an operational update. Final...
Dec 26, 2018 07:20 am ET
Consolidated Research: 2019 Summary Expectations for NextEra Energy, Gogo, Stryker, Aerohive Networks, Adtalem Global Education, and RCI Hospitality — Fundamental Analysis, Key Performance Indications
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of NextEra Energy, Inc. (NYSE:NEE), Gogo Inc. (NASDAQ:GOGO), Stryker...
Dec 04, 2018 03:30 pm ET
Stryker increases dividend 11%, declaring a $0.52 per share quarterly dividend
Kalamazoo, Michigan – December 4, 2018 – Stryker Corporation (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on January 31, 2019 to shareholders of record at the close of business on...
Nov 27, 2018 03:06 pm ET
Stryker announces pricing of €2.25 billion senior notes offering
Stryker (NYSE:SYK) announced today that it has priced the following notes: (i) €550 million aggregate principal amount of the Company’s 1.125% Notes due 2023 (the “2023 Notes”), (ii) €750 million aggregate principal amount of the Company’s 2.125%...
Nov 20, 2018 12:30 pm ET
Stryker to participate in Evercore ISI HealthCONx Conference
Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts. Katherine Owen, Vice President, Strategy and Investor Relations, will represent...
Nov 19, 2018 04:05 pm ET
K2M Group Holdings, Inc. Announces Fundamental Change With Respect to its 3.00% Convertible Senior Notes due 2025 and 4.125% Convertible Senior Notes due 2036
K2M Group Holdings, Inc. (“K2M”) today announced that, in connection with the closing of its merger with a subsidiary of Stryker Corporation (NYSE:SYK), a “Fundamental Change” has occurred under the applicable indentures governing K2M’s outstanding...
Nov 09, 2018 08:10 am ET
Stryker completes acquisition of K2M
Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, Inc., a global leader of complex spine and minimally invasive solutions. "K2M's broad product portfolio and robust pipeline complement...
Nov 06, 2018 07:40 am ET
Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP — Future Expectations, Projections Moving into 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Stryker Corporation (NYSE:SYK), Anavex Life Sciences Corp. (NASDAQ:AVXL),...
Oct 22, 2018 09:00 am ET
Oct 15, 2018 01:54 pm ET
MERGER ALERT – EGN, KTWO and RLJE: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi Korsinsky, LLP: Levi Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Energen Corporation (NYSE: EGN) Merger...
Oct 15, 2018 09:25 am ET
Analysis: Positioning to Benefit within PTC, H&R Block, GenMark Diagnostics, American International Group, Newmont Mining, and Stryker — Research Highlights Growth, Revenue, and Consolidated Results
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of PTC Inc. (NASDAQ:PTC), H Block, Inc. (NYSE:HRB), GenMark Diagnostics,...
Sep 21, 2018 03:17 pm ET
MERGER ALERT – IVTY, EGL and ESND: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi Korsinsky, LLP: Levi Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Invuity, Inc. (NASDAQGM: IVTY) Merger...
Sep 14, 2018 02:03 pm ET
MERGER ALERT – IVTY and EGL: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi Korsinsky, LLP: Levi Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Invuity, Inc. (NASDAQGM: IVTY) Merger...
Sep 12, 2018 11:23 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Invuity, Inc. to Stryker Corporation for $7.40 Per Share is Fair to Shareholders
The following statement is being issued by Levi Korsinsky, LLP: To: All Persons or Entities who purchased Invuity, Inc. (“Invuity” or the “Company”) (NASDAQGM: IVTY) stock prior to September 11, 2018. You are hereby notified that Levi ...
Sep 11, 2018 09:51 am ET
Invuity (IVTY) Alert: Johnson Fistel Investigates Proposed Sale of Invuity, Inc.; Is $ $7.40 a Fair Price?
SAN DIEGO, Sept. 11, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Invuity, Inc. (NASDAQ: IVTY) ("Invuity") breached their fiduciary duties in connection with the proposed sale of the Company to Stryker Corporation (NYSE: SYK).
Sep 11, 2018 08:00 am ET
Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash
Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.